A detailed history of Avantax Advisory Services, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 5,635 shares of NTRA stock, worth $914,616. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,635
Previous 8,104 30.47%
Holding current value
$914,616
Previous $1.03 Million 13.4%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

SELL
$117.67 - $174.0 $290,527 - $429,606
-2,469 Reduced 30.47%
5,635 $892,000
Q3 2024

Nov 13, 2024

SELL
$97.75 - $129.67 $28,934 - $38,382
-296 Reduced 3.52%
8,104 $1.03 Million
Q2 2024

Aug 09, 2024

BUY
$85.28 - $112.6 $716,352 - $945,840
8,400 New
8,400 $909,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.